| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/03/2015 | US8946394 Conjugate for photodynamic diagnosis or therapy and method for preparing same |
| 02/03/2015 | US8946379 Bladder cancer specific ligand peptides |
| 02/03/2015 | US8946292 Formulations of low dose diclofenac and beta-cyclodextrin |
| 02/03/2015 | US8946286 Organic amine salts of aminobenzoic acid derivatives and method for producing same |
| 02/03/2015 | US8946285 Oligomer-opioid agonist conjugates |
| 02/03/2015 | US8946277 Clonidine formulations in a biodegradable polymer carrier |
| 02/03/2015 | US8946276 High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis |
| 02/03/2015 | US8946275 Treatment of cancer using hypoxia activated prodrugs |
| 02/03/2015 | US8946229 Formulations |
| 02/03/2015 | US8946209 Compositions and methods for treating and preventing urolithiasis and conditions associated therewith |
| 02/03/2015 | US8946208 Non-aqueous pharmaceutical composition |
| 02/03/2015 | US8946184 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 02/03/2015 | US8946178 Compositions and methods for treatment of pouchitis |
| 02/03/2015 | US8946175 Stabilized immunomodulatory oligonucleotides |
| 02/03/2015 | US8946170 Sustained release siRNA for ocular drug delivery |
| 02/03/2015 | US8946169 SPARC and methods of use thereof |
| 02/03/2015 | US8946168 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 02/03/2015 | US8946167 Pharmaceutical compositions containing plasma protein |
| 02/03/2015 | US8946163 Cross-linked collagen comprising metallic anticancer agents |
| 02/03/2015 | US8946161 Method of treatment using stable liquid formulation of G-CSF |
| 02/03/2015 | US8946156 Albumin Fusion Proteins |
| 02/03/2015 | US8945927 Polymers for delivering molecules of interest |
| 02/03/2015 | US8945897 Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
| 02/03/2015 | US8945636 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care |
| 02/03/2015 | US8945627 Micelles for the solubilization of gossypol |
| 02/03/2015 | US8945625 Regulated delivery systems for inner ear drug application and uses thereof |
| 02/03/2015 | US8945623 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 02/03/2015 | US8945622 Sustained release composition of therapeutic agent |
| 02/03/2015 | US8945620 Solid pharmaceutical compositions containing pregabalin |
| 02/03/2015 | US8945619 Shell-and-core dosage form approaching zero-order drug release |
| 02/03/2015 | US8945617 Extrudate and methods of using said extrudate |
| 02/03/2015 | US8945614 Oral drug delivery system |
| 02/03/2015 | US8945609 Thermosetting neutralized chitosan composition forming a hydrogel, lyophilizate, and processes for producing the same |
| 02/03/2015 | US8945608 Composition and method to alleviate joint pain |
| 02/03/2015 | US8945604 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication |
| 02/03/2015 | US8945603 Sodium channel blocker delivery system with scleral lens |
| 02/03/2015 | US8945602 Porous photonic crystals for drug delivery to the eye |
| 02/03/2015 | US8945571 Targeted immunoconjugates |
| 02/03/2015 | US8945570 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 02/03/2015 | US8945554 Class I anti-CEA antibodies and uses thereof |
| 02/03/2015 | US8945551 Biopolymer hybrid gel-depot delivery system |
| 02/03/2015 | US8945543 Stabilizer for protein preparation comprising meglumine and use thereof |
| 02/03/2015 | US8945529 Biphasic lipid-vesicle compositions |
| 02/03/2015 | US8945516 Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| 02/03/2015 | US8945513 Star polymer nanoshells and methods of preparation thereof |
| 02/03/2015 | US8945511 Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3 |
| 02/03/2015 | US8945508 Dendrimer compositions and methods of synthesis |
| 02/03/2015 | US8945061 Otic formulations, methods and devices |
| 02/03/2015 | CA2790018C Formulations |
| 02/03/2015 | CA2775793C Siglec 15 antibodies in treating bone loss-related disease |
| 02/03/2015 | CA2759546C A method and composition for the control of ectoparasites |
| 02/03/2015 | CA2755084C Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/03/2015 | CA2705733C Reduced dose intravenous acetaminophen |
| 02/03/2015 | CA2698173C Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 02/03/2015 | CA2695952C Micro-particles, blood-substitute and method for forming same |
| 02/03/2015 | CA2645855C Modified release formulations containing drug-ion exchange resin complexes |
| 02/03/2015 | CA2608463C Compounds, compositions containing such compounds, and methods of treatment of metastatic melanoma and other cancers |
| 02/03/2015 | CA2603143C Improved botulinum toxin compositions |
| 01/29/2015 | WO2015013675A1 Spherical nucleic acid-based constructs as immunoregulatory agents |
| 01/29/2015 | WO2015013566A1 Nanoemulsions of hydrophobic platinum derivative |
| 01/29/2015 | WO2015013448A1 Treatment of pancreatic cancer with a combination of a hypoxia-acti vated prodrug and a taxane |
| 01/29/2015 | WO2015013341A1 Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders |
| 01/29/2015 | WO2015013169A2 Bioconjugates of synthetic apelin polypeptides |
| 01/29/2015 | WO2015012904A2 Antibody-sn-38 immunoconjugates with a cl2a linker |
| 01/29/2015 | WO2015012781A1 Medicinal agent exhibiting cardioprotective effect |
| 01/29/2015 | WO2015012365A1 Pharmaceutical preparation |
| 01/29/2015 | WO2015011977A1 Subcutaneous injection preparation for inducing bovine superovulation |
| 01/29/2015 | WO2015011675A1 Nanoassembled complexes of nucleic acids, avidin and biotinylated compounds for use as carriers for intracellular delivery |
| 01/29/2015 | WO2015011633A1 Compositions and methods for delivering messenger rna |
| 01/29/2015 | WO2015011308A1 Method for preserving and stabilising proteins, which can be used for industrial development of formulations of sanitary, pharmaceutical and cosmetic products |
| 01/29/2015 | WO2015011211A1 Photo-responsive spiropyran-based n-isopropylacrylamide (nipam) gels |
| 01/29/2015 | WO2015011199A1 Stabilized antibody compositions |
| 01/29/2015 | WO2015011188A1 Fibroin-based pharmaceutical spray compositions for the treatment of skin lesions |
| 01/29/2015 | WO2015011104A1 Polysaccharide hydrogels for injection with tunable properties |
| 01/29/2015 | WO2015010439A1 Pharmaceutical, water-soluble and antifungal macromolecular compound |
| 01/29/2015 | US20150032045 Photolabile compounds |
| 01/29/2015 | US20150031863 Conjugating amines |
| 01/29/2015 | US20150031861 Chemical Modification of Antibodies |
| 01/29/2015 | US20150031851 Hmgn2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 01/29/2015 | US20150031832 Carrier nanoparticles and related compositions, methods and systems |
| 01/29/2015 | US20150031770 Pharmaceutical Formulations of HDAC Inhibitors |
| 01/29/2015 | US20150031753 Complexing agents for compositions containing inclusion complexes |
| 01/29/2015 | US20150031752 Coated lipid complexes and their use |
| 01/29/2015 | US20150031745 Nanoconjugates able to cross the blood-brain barrier |
| 01/29/2015 | US20150031743 Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
| 01/29/2015 | US20150031732 Febuxostat solid dispersion |
| 01/29/2015 | US20150031724 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 01/29/2015 | US20150031718 Pharmaceutical Formulation Containing Opioid Agonist, Opioid Antagonist and Gelling Agent |
| 01/29/2015 | US20150031654 Natural combination hormone replacement formulations and therapies |
| 01/29/2015 | US20150031647 Taste masked dispersible tablets |
| 01/29/2015 | US20150031646 Carrier enhancing absorption of medication |
| 01/29/2015 | US20150031644 Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof |
| 01/29/2015 | US20150031632 Orally Disintegrating Compositions of Linaclotide |
| 01/29/2015 | US20150031631 Pharmaceutical compositions and related methods of delivery |
| 01/29/2015 | US20150031630 Peptide Pharmaceuticals |
| 01/29/2015 | US20150031629 Ophthalmic formulation derived from silk protein |
| 01/29/2015 | US20150031628 Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 01/29/2015 | US20150031625 Targeted vectors for cancer immunotherapy |
| 01/29/2015 | US20150031617 Use of thymosin alpha for treatment of purulent rhinosinusitis |
| 01/29/2015 | US20150031610 Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins |